HLA-DMA and HLA-DMB Gene Expression Functions Through the Conserved S-X-Y Region

Journal of Immunology

Volumn 158, Issue 10, 1997, Pages 4812-4821

  Westerheide, Sandy D ^a   Louis Plence, Pascale ^a   Ping, Dongsheng ^a   He, Xiao Fei ^a   Boss, Jeremy M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GAMMA INTERFERON; H2 M ANTIGENS; H2-M ANTIGENS; HLA ANTIGEN CLASS 2; HLA D ANTIGEN; HLA DMB; HLA-DMB; MESSENGER RNA; TRANSCRIPTION FACTOR; X BOX BINDING PROTEIN (RF X); X BOX BINDING PROTEIN (RF-X);

ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL CULTURE; GENE; GENETICS; HUMAN; MACROMOLECULE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION;

B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; DNA-BINDING PROTEINS; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HUMANS; INTERFERON TYPE II; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031570110     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Anderson, M. S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for the major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
2. Peterson, M., and J. Miller. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature 345:172.
3. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707.
4. Lamb, C. A., and P. Cresswell. 1992. Assembly and transport properties on invariant chain trimers and HLA-DR invariant chain complexes. J. Immunol. 148: 3478.
5. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S. L. Schmid, V. Quranta, and P. A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600.
6. Neefjes, J. J., V. Stollorz, P. J. Peters, H. J. Geuze, and H. L. Ploegh. 1990. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61:171.
7. Peters, P. J., J. J. Neefjes, V. Oorschot, H. L. Ploegh, and H. J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669.
8. Teyton, L., D. O'Sullivan, P. W. Dickson, V. Lotteau, A. Sette, P. Fink, and P. A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348:39.
9. Stern, L., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:213.
10. Fling, S. P., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554.
11. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551.
12. Avva, R. R., and P. Cresswell. 1994. In vivo and in vitro formation and dissodation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763.
13. Riberdy, J. M., J. R. Newcomb, M. J. Surnam, J. A. Barbosa, and P. Cresswell. 1992. HLA-DR molecules from an antigen-processing mutant sell line are associated with invariant chain peptides. Nature 360:474.
14. Sette, A., S. Ceman, R. T. Kubo, K. Sakaguchi, E. Apella, D. F. Hunt, T. A. Davis, H. Michel, J. Shabanowitz, R. Rudersdorf, H. M. Grey, and R. DeMars. 1992. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258:1801.
15. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen processing detect in T2 cells. Immunity 1:595.
16. Sanderson, F., C. Thomas, J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4:87.
17. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618.
18. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
19. Pober, J. S., T. Collins, M. A. Gimbrone, Jr., R. S. Cotran, J. D. Gitlin, W. Fiers, C. Clayberger, A. M. Krensky, S. J. Burakoff, and C. S. Reiss. 1983. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305:726.
20. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class II transcription. In Annual Reviews of Immunology, 10th Ed. W. E. Paul, C. Garrision Fathman, and H. Metzger, eds. Annual Reviews, Inc., Palo Alto, p. 13.
21. Boss, J. M., and J. L. Strominger. 1986. Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc. Natl. Acad. Sci. USA 83:9139.
22. Basta, P. V., P. A. Sherman, and J. P. Ting. 1988. Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line. Proc. Natl. Acad. Sci. USA 85:8618.
23. Brown, A. M., K. L. Wright, and J. P.-Y. Ting. 1993. Human major histocompatibility complex class II-associated invariant chain gene promoter: functional analysis and in vivo protein/DNA interactions of constitutive and IFN-γ-induced expression. J. Biol. Chem. 268:26328.
24. Barr, C. L., and G. F. Saunders. 1991. Interferon-gamma-inducible regulation of the human invariant chain. J. Biol. Chem. 266:3475.
25. Collins, T., A. J. Korman, C. T. Wake, J. M. Boss, D. J. Kappes, W. Fiers, K. A. Ault, M. A. Gimbrone, Jr., J. L. Strominger, and J. S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917.
26. Kern, I., V. Steimle, C. Siegrist, and B. Mach. 1996. The two novel MHC class II trans-activators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7:1295.
27. Chang, C., and R. A. Flavell. 1995. Class II trans-activator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 765:765.
28. Kelly, A. P., J. J. Monaco, S. Cho, and J. Trowsdale. 1991. A new human HLA class II-related locus, DM. Nature 353:571.
29. Griscelli, C., B. Lisowska-Grospierre, and B. Mach. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic. Rev. 1:135.
30. Lisowska-Grospierre, B., D. J. Charron, C. de Preval, A. Durandy, C. Griscelli, and B. Mach. 1985. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J. Clin. Invest. 76:381.
31. Gladstone, P., and D. Pious. 1980. Identification of a trans-acting function regulating HLA-DR expression in a DR-negative B cell variant. Somat. Cell Genet. 6:285.
32. Reith, W., S. Satola, C. Herreo-Sanchez, I. Amaldi, B. Lisowska-Grospierre. C. Griscelli, M. R. Hadam, and B. Mach. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897.
33. Benichou, B., and J. L. Strominger. 1991. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88: 4285.
34. Seidl, C., C. Saraiya, Z. Osterweil, Y. P. Fu, and J. S. Lee. 1992. Genetic complexity of regulatory mutants defective for HLA class II expression. J. Immunol. 148:1576.
35. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II trans-activator mutated in hereditary MHC class II deficiency (bare lymphocyte syndrome). Cell 75:135.
36. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II trans-activator (CIITA). Immunity 2:533.
37. Hasegawa, S. L., J. L. Riley, J. H. Sloan, and J. M. Boss. 1993. Protease treatment of nuclear extracts distinguishes between class II major histocompatibility complex X1 box DNA-binding proteins in wild type and class II deficient B cells. J. Immunol. 150:1781.
38. Herrero Sanchez, C., W. Reith, P. Silacci, and B. Mach. 1992. The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol. Cell. Biol. 12:4076.
39. Kouskoff, V., R. M. Mantovani, S. M. Candeias, A. Dorn, A. Staub. B. Lisowska-Grospierre, C. Griscelli, C. O. Benoist, and D. J. Mathis. 1991. NF-X, a transcription factor implicated in MHC class II gene regulation. J. Immunol. 146:3197.
40. + cell types. J. Immunol. 146:1361.
41. Sloan, J. H., S. L. Hasegawa, and J. M. Boss. 1992. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. J. Immunol. 148:2591.
42. Tsang, S. Y., M. Nakanishi, and B. M. Peterlin. 1988. B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc. Natl. Acad. Sci. USA 85:8598.
43. Sloan, J. H., and J. M. Boss. 1988. Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines. Proc. Natl. Acad. Sci. USA 85:8186.
44. Hasegawa, S. L., and J. M. Boss. 1991. Two distinct B cell factors bind the HLA-DRA X box region and recognize different subsets of MHC class II promoters. Nucleic Acids Res. 19:6269.
45. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709.
46. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313.
47. Radley, E., R. P. Alderton, A. Kelly, J. Trowsdale, and S. Beck. 1994. Genomic organization of HLA-DMA and HLA-DMB. J. Biol. Chem. 269:18834.
48. Epstein, M. A., B. G. Achong, Y. M. Barr, B. Zajac, G. Henle, and W. Henle. 1966. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer. Inst. 37:547.
49. Accolla, R. S. 1983. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J. Exp. Med. 157:1053.
50. Shrikant, P., D. J. Benos, L. P. Tang, and E. N. Benveniste. 1996. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells: involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J. Immunol. 156:1307.
51. Shaman, J., E. von Scheven, P. Morris, M. Y. Chang, and E. Mellins. 1995. Analysis of HLA-DMB mutants and -DMB genomic structure. Immunogenetics 41:117.
52. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044.
53. Yoon, K., M. A. Thiede, and G. A. Rodan. 1988. Alkaline phosphatase as a reporter enzyme. Gene 66:11.
54. Riley, J. L., and J. M. Boss. 1993. Class II MHC transcriptional mutants are defective in higher order complex formation. J. Immunol. 151:6942.
55. Ping, D., P. L. Jones, and J. M. Boss. 1996. TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the murine monocyte chemoattractant protein-1 (MCP-1/JE) gene. Immunity 4:455.
56. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
57. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1996. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197.
58. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
59. Hasegawa, S. L., J. H. Sloan, W. Reith, B. Mach, and J. M. Boss. 1991. Regulatory factor-X binding to mutant HLA-DRA promoter sequences. Nucleic Acids Res. 19:1243.
60. Peleraux, A., L. Karlsson, J. Chambers, and P. A. Peterson. 1996. Genomic organization of a mouse MHC class II region including the H2-M and Lmp2 loci. Immunogenetics 43:204.
61. Spana, C., and V. G. Corces. 1990. DNA bending is a determinant of binding specificity for a Drosophila zinc finger protein. Genes Dev. 4:1505.
62. Pober, J. S., T. Collins, Jr., Gimbone, M. A., R. S. Cotran, J. D. Gitlin, W. Fiers, C. Clayberber, A. M. Krensky, S. J. Burakoff, and C. S. Reiss. 1983. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305:726.
63. Basta, P. V., P. A. Sherman, and J. P. Ting. 1987. Identification of an interferon-gamma response region 5′ of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiform lines. J. Immunol. 138:1275.
64. Kara, C. J., and L. H. Glimcher. 1993. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo. J. Immunol. 150: 4934.
65. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82:155.
66. Nocera, A., S. Barocci, R. De Palma, and J. Gorski. 1993. Analysis of transcripts of genes located within the HLA-D region in B cells from an HLA-severe combined immunodeficiency individual. Hum. Immunol. 38:231.
67. Jabrane-Ferrat, N., J. D. Fontes, J. M. Boss, and B. M. Peterlin. 1997. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol. Cell. Biol. 16:4683.
68. Wright, K. L., T. L. Moore, B. J. Vilen, A. M. Brown, and J. P.-Y. Ting. 1995. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J. Biol. Chem. 270:20978.
69. Wright, K. L., and J. P.-Y. Ting. 1992. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma. Proc. Natl. Acad. Sci. USA 89:7601.
70. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
71. Brown, A. M., C. L. Barr, and J. P.-Y. Ting. 1991. Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-γ-induced expression of human class II-associated invariant chain gene. J. Immunol. 146: 3183.
72. Brown, A. M., M. W. Linhoff, B. Stein, K. L. Wright, A. S. Baldwin, Jr., P. V. Basta, and J. P.-Y. Ting. 1994. Function of NF-κB/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-κB subunits. Mol. Cell. Biol. 14:2926.
73. Louis, P., R. Vincent, P. Cavadore, J. Clot, and J.-F. Eliaou. 1994. Differential transcriptional activities of HLA-DR genes in the various haplotypes. J. Immunol. 153:5059.